Literature DB >> 19777445

Purification and characterization of heparan sulfate from human primary osteoblasts.

Sadasivam Murali1, Kerry J Manton, Vinalia Tjong, Xiaodi Su, Larisa M Haupt, Simon M Cool, Victor Nurcombe.   

Abstract

Heparan sulfate (HS) is a linear, highly variable, highly sulfated glycosaminoglycan sugar whose biological activity largely depends on internal sulfated domains that mediate specific binding to an extensive range of proteins. In this study we employed anion exchange chromatography, molecular sieving and enzymatic cleavage on HS fractions purified from three compartments of cultured osteoblasts-soluble conditioned media, cell surface, and extracellular matrix (ECM). We demonstrate that the composition of HS chains purified from the different compartments is structurally non-identical by a number of parameters, and that these differences have significant ramifications for their ligand-binding properties. The HS chains purified of conditioned medium had twice the binding affinity for FGF2 when compared with either cell surface or ECM HS. In contrast, similar binding of BMP2 to the three types of HS was observed. These results suggest that different biological compartments of cultured cells have structurally and functionally distinct HS species that help to modulate the flow of HS-dependent factors between the ECM and the cell surface.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19777445     DOI: 10.1002/jcb.22340

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  The effect of human bone marrow stroma-derived heparan sulfate on the ex vivo expansion of human cord blood hematopoietic stem cells.

Authors:  Diah S Bramono; David A Rider; Sadasivam Murali; Victor Nurcombe; Simon M Cool
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

2.  Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2).

Authors:  Diah S Bramono; Sadasivam Murali; Bina Rai; Ling Ling; Wei Theng Poh; Zophia Xuehui Lim; Gary S Stein; Victor Nurcombe; Andre J van Wijnen; Simon M Cool
Journal:  Bone       Date:  2011-12-28       Impact factor: 4.398

3.  In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic.

Authors:  Lionel Faivre; Véronique Parietti; Fernando Siñeriz; Sandrine Chantepie; Marie Gilbert-Sirieix; Patricia Albanese; Jérôme Larghero; Valérie Vanneaux
Journal:  Stem Cell Res Ther       Date:  2016-01-07       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.